Substituted 2H-isoquinolin-1-ones as potent Rho-kinase inhibitors: Part 3, aryl substituted pyrrolidines
Authors:
- 1 June 2010
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 20 (12) , 3746-3749
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Therapeutic potential of RhoA/Rho kinase inhibitors in pulmonary hypertensionBritish Journal of Pharmacology, 2008
- Detection of myosin light chain phosphorylation—A cell-based assay for screening Rho-kinase inhibitorsBiochemical and Biophysical Research Communications, 2008
- Rho-Kinase Inhibitors for Cardiovascular Disease2008
- Rho-kinase phosphorylates eNOS at threonine 495 in endothelial cellsBiochemical and Biophysical Research Communications, 2007
- Rho Kinase Inhibition Improves Endothelial Function in Human Subjects With Coronary Artery DiseaseCirculation Research, 2006
- Involvement of the Rho-Kinase/Myosin Light Chain Kinase Pathway on Human Monocyte Chemotaxis Induced by ATL-1, an Aspirin-Triggered Lipoxin A4 Synthetic AnalogThe Journal of Immunology, 2005
- ROCKs: multifunctional kinases in cell behaviourNature Reviews Molecular Cell Biology, 2003
- Rho kinase is required for CCR7‐mediated polarization and chemotaxis of T lymphocytesFEBS Letters, 2003
- Rho/Rho-kinase mediated signaling in physiology and pathophysiologyJournal of Molecular Medicine, 2002
- Regulation and Functions of Rho-Associated KinaseExperimental Cell Research, 2000